Literature DB >> 28927889

Epidemiology of Eczema Herpeticum in Hospitalized U.S. Children: Analysis of a Nationwide Cohort.

Derek Y Hsu1, Kanade Shinkai2, Jonathan I Silverberg3.   

Abstract

Eczema herpeticum (EH) is characterized by viral infection of a preexisting inflammatory dermatosis and is associated with considerable morbidity. In this cross-sectional study, we sought to determine the incidence, risk factors, comorbidities, costs of care, length of stay, and mortality in hospitalized U.S. children with EH. The Nationwide Inpatient Sample 2002-2012, containing a 20% sample of all U.S. hospitalizations, was analyzed. We used a validated approach involving InternationalClassification of Diseases, Ninth Revision-Clinical Modification codes to identify patients primarily admitted for EH (n = 4,655 weighted). The mean annual incidence of hospitalization for EH per million children ranged from 4.03 to 7.30, increasing significantly from 2008 to 2012. EH was associated with younger age (odds ratio [95% confidence interval] for 3-4 years = 1.29 [1.02-1.64]) and nonwhite race/ethnicity (black = 2.93 [2.35-3.66], Asian= 4.41 [3.34-5.83], Native American = 2.96 [1.51-5.78]) but was less likely to occur in areas with lower income quartiles (quartile 1, 0.66 [0.53-0.84]; quartile 2, = 0.68 [0.54-0.87]; quartile 3, 0.70 [0.56-0.88]). EH was associated with atopic dermatitis (11.72 [9.48-14.49]). Increased length of stay and costs of care were associated with Asian race. Mean length of stay was 3.86 ± 0.09 days, and mean cost of care was $5,237.6 ± 160.6. Overall mortality was 0.1%. EH in hospitalized children poses a substantial burden to the health care system.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28927889     DOI: 10.1016/j.jid.2017.08.039

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  6 in total

1.  Risk of herpesvirus, serious and opportunistic infections in atopic dermatitis: a population-based cohort study.

Authors:  J Wan; D B Shin; M N Syed; K Abuabara; A R Lemeshow; J M Gelfand
Journal:  Br J Dermatol       Date:  2022-01-20       Impact factor: 11.113

2.  Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis.

Authors:  Lawrence F Eichenfield; Thomas Bieber; Lisa A Beck; Eric L Simpson; Diamant Thaçi; Marjolein de Bruin-Weller; Mette Deleuran; Jonathan I Silverberg; Carlos Ferrandiz; Regina Fölster-Holst; Zhen Chen; Neil M H Graham; Gianluca Pirozzi; Bolanle Akinlade; George D Yancopoulos; Marius Ardeleanu
Journal:  Am J Clin Dermatol       Date:  2019-06       Impact factor: 7.403

3.  Eczema Herpeticum in children with burns.

Authors:  Fatima Naumeri; Sushil Rijal; Abdul Rehman Rashid; Hafiz Mahmood Ahmad
Journal:  Pak J Med Sci       Date:  2021 Mar-Apr       Impact factor: 1.088

4.  Prevalence of adult eczema, hay fever, and asthma, and associated risk factors: a population-based study in the northern Grassland of China.

Authors:  Xiaoyan Wang; Yan Zhuang; Yanlei Chen; Hongtian Wang; Xueyan Wang
Journal:  Allergy Asthma Clin Immunol       Date:  2021-03-09       Impact factor: 3.406

5.  Characteristics of hospitalized dermatomyositis patients with underlying malignancy: a nationally representative retrospective cohort study.

Authors:  Raghav Tripathi; Anthony P Fernandez
Journal:  Arch Dermatol Res       Date:  2020-08-17       Impact factor: 3.017

Review 6.  The infectious complications of atopic dermatitis.

Authors:  Vivian Wang; Juri Boguniewicz; Mark Boguniewicz; Peck Y Ong
Journal:  Ann Allergy Asthma Immunol       Date:  2020-08-07       Impact factor: 6.347

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.